European Respiratory Review

Article	Citations
The respiratory microbiome and nontuberculous mycobacteria: an emerging concern in human health	197
Interventions for the management of malignant pleural effusions: an updated network meta-analysis	161
The measurement properties of tests and tools used in cystic fibrosis studies: a systematic review	159
The application of barium oesophagography in patients with suspected tracheo-oesophageal fistula: preferred or avoided?	153
The role of telemonitoring in patients on home mechanical ventilation	102
Non-typeableHaemophilus influenzaeairways infection: the next treatable trait in asthma?	97
European Respiratory Review, list of peer reviewers 2022	91
Phage therapy for pulmonary infections: lessons from clinical experiences and key considerations	85
Selection of potential targets for stratifying congenital pulmonary airway malformation patients with molecular imaging: is MUC1 the one?	82
A critical interpretive synthesis of the lived experiences and health and patient-reported outcomes of people living with COPD who isolated during the COVID-19 pandemic	82
Association of preserved ratio impaired spirometry with mortality: a systematic review and meta-analysis	66
Metabolomics and microbiome profiling as biomarkers in obstructive sleep apnoea: a comprehensive review	65
Training in interventional pulmonology: the European and US perspective	63
Prevalence, risk factors and treatments for post-COVID-19 breathlessness: a systematic review and meta-analysis	62
Reply to: “Nicotine or tobacco abstinence?”	60
ERS/EAACI statement on adherence to international adult asthma guidelines	59
Liposomal drug delivery to manage nontuberculous mycobacterial pulmonary disease and other chronic lung infections	56
Cardiopulmonary exercise testing in interstitial lung diseases and the value of ventilatory efficiency	55
Parasitic lung diseases	54
Molecular monitoring of lung allograft health: is it ready for routine clinical use?	52
Positive airway pressure therapy for post-stroke sleep disordered breathing: a systematic review, meta-analysis and meta-regression	51
The world of rare interstitial lung diseases	50
New trends in pulmonary hypertension	49
Lost in translation: a neglected mTOR target for lymphangioleiomyomatosis	46
Cough symptom severity in patients with refractory or unexplained chronic cough: a systematic survey and conceptual framework	45

Preclinical models of maternal asthma and progeny outcomes: a scoping review	43
Medication adherence to CFTR modulators in patients with cystic fibrosis: a systematic review	43
Natural killer cells in the lung: potential role in asthma and virus-induced exacerbation?	42
Ventilatory efficiency and its clinical and prognostic value in adults with cystic fibrosis	42
Peripheral blood monocyte count and outcomes in patients with interstitial lung disease: a systematic review and meta-analysis	41
Ergonomics of bronchoscopy: good advice or a pain in the neck?	40
The ventilatory efficiency and its clinical and prognostic value in cardiorespiratory disorders	39
Resectable non-stage IV nonsmall cell lung cancer: the surgical perspective	39
Exacerbations of bronchiectasis	38
Perioperative approach to precapillary pulmonary hypertension in non-cardiac non-obstetric surgery	38
Eosinophils and eosinophilic immune dysfunction in health and disease	37
The efficacy of immune checkpoint inhibitors in thoracic malignancies	37
Opioids for the palliation of symptoms in people with serious respiratory illness: a systematic review and meta-analysis	36
Exploring the 175-year history of spirometry and the vital lessons it can teach us today	35
Ventilation/perfusion mismatch is not the sole reason for hypoxaemia in early stage COVID-19 patients	35
Smouldering fire or conflagration? An illustrated update on the concept of inflammation in pulmonary arterial hypertension	34
Interstitial pneumonia with autoimmune features: challenges and controversies	34
Polyphenols, flavonoids and inflammasomes: the role of cigarette smoke in COPD	34
European Respiratory Review, list of peer reviewers 2021	33
Growing from common ground: nontuberculous mycobacteria and bronchiectasis	33
Predicting the pulmonary effects of long-term e-cigarette use: are the clouds clearing?	33
European Respiratory Review, list of peer reviewers 2023	32
Does pulmonary rehabilitation address treatable traits? A systematic review	32
Association between second-hand smoke exposure and lung cancer risk in never-smokers: a systematic review and meta-analysis	31
Occupation and SARS-CoV-2 in Europe: a review	31
Unravelling the mechanisms driving multimorbidity in COPD to develop holistic approaches to patient-centred care	31
The epithelial era of asthma research: knowledge gaps and future direction for patient care	31
Multicomponent services for symptoms in serious respiratory illness: a systematic review and meta-analysis	30
Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis	30
Deep learning for pneumothorax diagnosis: a systematic review and meta-analysis	30
Post-acute COVID-19 syndrome	29
Chronic lung diseases: entangled in extracellular matrix	29
Asthma-COPD overlap: current understanding and the utility of experimental models	29
Lung transplantation for interstitial lung disease	28
Burden of respiratory syncytial virus infection in older and high-risk adults: a systematic review and meta-analysis of the evidence from developed countries	28
Management ofMycobacterium aviumcomplex andMycobacterium abscessuspulmonary disease: therapeutic advances and emerging treatments	28
“Design of pulmonary rehabilitation programmes during acute exacerbations of COPD: a systematic review and network meta-analysis.” Ana Machado, Pedro Matos Silva, Vera Afreixo, Cátia Caneiras, Chris B	27
“Exercise intolerance in pulmonary arterial hypertension: insight into central and peripheral pathophysiological mechanisms.” S. Malenfant, M. Lebret, É. Breton-Gagnon,et al.Eur Respir Rev	27
Understanding the pathogenesis of occupational coal and silica dust-associated lung disease	27
“Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis.” M. Kolb, B. Crestani and T.M. Maher.Eur Respir Rev2023; 32: 220206.	27
Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD	26
Digital remote maintenance inhaler adherence interventions in COPD: a systematic review and meta-analysis	26
Phosphodiesterase 4B inhibition: a potential novel strategy for treating pulmonary fibrosis	26
Macrophages and the microbiome in chronic obstructive pulmonary disease	26
Sarcoidosis-associated pulmonary fibrosis: joining the dots	26
Silicotuberculosis: a critical narrative review	25
Incidental discovery of interstitial lung disease: diagnostic approach, surveillance and perspectives	25
Natural variability in the disease course of SSc-ILD: implications for treatment	24
Impact of climate change on paediatric respiratory health: pollutants and aeroallergens	24
Exertional ventilation/carbon dioxide output relationship in COPD: from physiological mechanisms to clinical applications	24

Global respiratory health priorities at the beginning of the 21st century	24
Update on molecular pathology and role of liquid biopsy in nonsmall cell lung cancer	23
Severe community-acquired pneumonia	23
Social determinants of advanced chronic respiratory interventions: a scoping review	23
Cardiac consequences of intermittent hypoxia: a matter of dose? A systematic review and meta-analysis in rodents	23
Quality of life in patients with chronic respiratory failure on home mechanical ventilation	22
Clinical–radiological–pathological correlation in pulmonary hypertension with unclear and/or multifactorial mechanisms	22
Antineutrophil cytoplasmic antibody-associated interstitial lung disease: a review	21
Extracellular vesicle-mediated cellular crosstalk in lung repair, remodelling and regeneration	21
Impairment of hypoxic pulmonary vasoconstriction in acute respiratory distress syndrome	21
Bronchiectasis in Asia: a review of current status and challenges	21
Post-COVID-19 dyspnoea and pulmonary imaging: a systematic review and meta-analysis	21
Lung cancer occurrence after an episode of tuberculosis: a systematic review and meta-analysis	21
Correction to subglottic secretion drainage for preventing ventilator-associated pneumonia: an overview of systematic reviews and an updated meta-analysis	21
Holy Grail: the journey towards disease modification in asthma	21
The impact of therapeutics on mortality in hospitalised patients with COVID-19: systematic review and meta-analyses informing the European Respiratory Society living guideline	20
Pulmonary veno-occlusive disease: illustrative cases and literature review	20
Epidemiology of severe asthma in children: a systematic review and meta-analysis	20
The association between alcohol consumption and pulmonary function: a scoping review	20
No smoke without fire: the impact of cigarette smoking on the immune control of tuberculosis	20
A scoping review on the risk of tuberculosis in specific population groups: can we expand the World Health Organization recommendations?	20
20 years of neuromuscular electrical stimulation in COPD	20
Common single nucleotide polymorphisms associated with idiopathic pulmonary fibrosis: a systematic review	20
Obesity, leptin and host defence ofStreptococcus pneumoniae: the case for more human research	20
Fixed-intensity exercise tests to measure exertional dyspnoea in chronic heart and lung populations: a systematic review	19
Role of autophagy in lung diseases and ageing	19
Impact of ageing and pregnancy on the minute ventilation/carbon dioxide production response to exercise	19
Developments in radiation techniques for thoracic malignancies	19
Management of asthma exacerbations in the paediatric population: a systematic review	19
The impact of outdoor air pollution on COVID-19: a review of evidence fromin vitro, animal, and human studies	19
Inhaled corticosteroids for the treatment of COVID-19	18
Lung cancer is also a hereditary disease	18
The nitric oxide–soluble guanylate cyclase–cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase	18
Predictors of sleep disordered breathing in children with Down syndrome: a systematic review and meta-analysis	18
Barriers to and facilitators of populational adherence to prevention and control measures of COVID-19 and other respiratory infectious diseases: a qualitative evidence synthesis	18
Human pluripotent stem cells for the modelling and treatment of respiratory diseases	18
The cystic fibrosis lung microenvironment alters antibiotic activity: causes and effects	18
State-of-the-art review of lung imaging in cystic fibrosis with recommendations for pulmonologists and radiologists from the “iMAging managEment of cySTic fibROsis” (MAESTRO) consortium	17
Evidence-based management of symptoms in serious respiratory illness: what is in our toolbox?	17
Treatable traits in asthma during pregnancy: a call for a shift towards a precision-based management approach	17
Epigenetics and sarcoidosis	17
Recent advances in the management of pulmonary hypertension with interstitial lung disease	17
Breathing techniques to reduce symptoms in people with serious respiratory illness: a systematic review	17
Advance care planning in patients with respiratory failure	17
E-cigarettes and nicotine abstinence: a meta-analysis of randomised controlled trials	17
“Subglottic secretion drainage for preventing ventilator-associated pneumonia: an overview of systematic reviews and an updated meta-analysis”. Diana P. Pozuelo-Carrascosa, Ángel Herráiz-Adillo, Celia	17
Sex, gender and the pulmonary physiology of exercise	17
“Noninvasive respiratory support after extubation: a systematic review and network meta-analysis”. A. Boscolo, T. Pettenuzzo, N. Sella, M. Zatta, M. Salvagno, M. Tassone, C. Pretto, A. Peralta, L. Mur	16
Recycling plastic: diagnosis and management of plastic bronchitis among adults	16
Airway epithelium in lung transplantation: a potential actor for post-transplant complications?	16
Toll-like receptor-agonist-based therapies for respiratory viral diseases: thinking outside the cell	16
“How will lung cancer screening and lung nodule management change the diagnostic and surgical lung cancer landscape?”. G. Hardavella, A. Frille, R. Chalela, K.B. Sreter, R.H. Petersen, N. Novoa and H.	16
New developments in locally advanced nonsmall cell lung cancer	16
Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe	16
Surgical and bronchoscopic pulmonary function-improving procedures in lung emphysema	15
Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis	15
Current evidence for COVID-19 therapies: a systematic literature review	15
Air pollution as an early determinant of COPD	15
Multiple breath washout and oscillometry after allogenic HSCT: a scoping review	15
Contemporary issues in the implementation of lung cancer screening	15
The re-emerging role of linoleic acid in paediatric asthma	15
Diagnostic workup of childhood interstitial lung disease	15
From treatable traits to GETomics in airway disease: moving towards clinical practice	15
Montelukast in paediatric asthma and allergic rhinitis: a systematic review and meta-analysis	15
Current unmet needs and potential solutions to uncontrolled asthma	15
Reference equations for oscillometry and their differences among populations: a systematic scoping review	15
The role of smoking in COVID-19 progression: a comprehensive meta-analysis	14
Respiratory muscle training in neuromuscular disease: a systematic review and meta-analysis	14
Paediatric sleep diagnostics in the 21st century: the era of “sleep-omics”?	14
The role of antibodies in tuberculosis diagnosis, prophylaxis and therapy: a review from the ESGMYC study group	14
Awake prone positioning for hypoxaemic respiratory failure: past, COVID-19 and perspectives	14
Non-Aspergillusmould lung infections	14
Patient-reported outcomes to assess dyspnoea in interstitial lung disease and pulmonary hypertension: a systematic literature review of measurement properties	14
Regenerative and translational medicine in COPD: hype and hope	14
Fine particulate matter manipulates immune response to exacerbate microbial pathogenesis in the respiratory tract	13
Multidisciplinary meeting review in nonsmall cell lung cancer: a systematic review and meta-analysis	13
Platelets: a potential role in chronic respiratory diseases?	13
Patient-reported outcomes and patient-reported outcome measures in interstitial lung disease: where to go from here?	12
Tuberous sclerosis complex for the pulmonologist	12
Nicotine or tobacco abstinence?	12

The relationship of early-life household air pollution with childhood asthma and lung function	12
Effects of continuous positive airway pressure therapy on glucose metabolism in patients with obstructive sleep apnoea and type 2 diabetes: a systematic review and meta-analysis	12
Hypoxaemia in the early stage of COVID-19: prevalence of physical or biochemical factors?	12
Fully integrating pathophysiological insights in COPD: an updated working disease model to broaden therapeutic vision	11
Managing respiratory muscle weakness during weaning from invasive ventilation	11
Cryptogenic organising pneumonia: current understanding of an enigmatic lung disease	11
Supplemental oxygen and noninvasive ventilation	11
Phenotype overlap in the natural history of asthma	11
Minute ventilation/carbon dioxide production in chronic heart failure	11
Stem cell therapy in pulmonary hypertension: current practice and future opportunities	10
Discordant diagnostic criteria for pneumonia in COPD trials: a review	10
Global birth prevalence of Robin sequence in live-born infants: a systematic review and meta-analysis	10
A systematic review of procedural and sampling techniques for cryobiopsy in interstitial lung disease	10
The evolving landscape of sex-based differences in lung cancer: a distinct disease in women	10
Identifying limitations to exercise with incremental cardiopulmonary exercise testing: a scoping review	10
Social determinants of respiratory health from birth: still of concern in the 21st century?	10
The effects of flow settings during high-flow nasal cannula oxygen therapy for neonates and young children	10
Physical activity measurements in individuals with interstitial lung disease: a systematic review and meta-analysis	10
Biologics in severe asthma: the role of real-world evidence from registries	10
Innovative three-dimensional models for understanding mechanisms underlying lung diseases: powerful tools for translational research	10
Biologic agents licensed for severe asthma: a systematic review and meta-analysis of randomised controlled trials	10
Correspondence regarding “Ventilatory efficiency in athletes, asthma and obesity”: different ventilatory phenotypes during exercise in obesity?	9
Clinical–imaging–pathological correlation in pulmonary hypertension associated with left heart disease	9
Disease burden associated with alpha-1 antitrypsin deficiency: systematic and structured literature reviews	9
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review	9
New drugs, new challenges in cystic fibrosis care	9
Just breathe: a review of sex and gender in chronic lung disease	9
Aspergillus-related lung disease in people with cystic fibrosis: can imaging help us to diagnose disease?	9
EMBARCing on a new era for bronchiectasis: a review series for the Seventh World Bronchiectasis Conference	9
Highlights from the International Chronic Thromboembolic Pulmonary Hypertension Congress 2021	8
The role of gene–ambient air pollution interactions in paediatric asthma	8
Phage therapy: breathing new tactics into lower respiratory tract infection treatments	8
Immune processes in the pathogenesis of chronic lung allograft dysfunction: identifying the missing pieces of the puzzle	8
Prognostic value of echocardiography-derived right ventricular dysfunction in haemodynamically stable pulmonary embolism: a systematic review and meta-analysis	8
New insights into acute and chronic respiratory failure: highlights from the Respiratory Failure and Mechanical Ventilation Conference 2022	8
Microplastic and plastic pollution: impact on respiratory disease and health	8
Infection and the microbiome in bronchiectasis	8
The role of vaccination in COPD: influenza, SARS-CoV-2, pneumococcus, pertussis, RSV and varicella zoster virus	8
Eradication treatment forPseudomonas aeruginosainfection in adults with bronchiectasis: a systematic review and meta-analysis	8
Endotyping COPD: hypoxia-inducible factor-2 as a molecular “switch” between the vascular and airway phenotypes?	8
Neutrophil extracellular traps in chronic lung disease: implications for pathogenesis and therapy	8
WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension	8
The ageing of people living with cystic fibrosis: what to expect now?	8
“Targeting interleukin-33 and thymic stromal lymphopoietin pathways for novel pulmonary therapeutics in asthma and COPD”. Ariel A. Calderon, Colin Dimond, David F. Choy, Rajita Pappu, Michele A. Grimb	8
Physical activity promotion interventions in chronic airways disease: a systematic review and meta-analysis	8
Sarcopenia in interstitial lung disease	7
Particulate matter-induced epigenetic modifications and lung complications	7
Mucolytics for acute exacerbations of chronic obstructive pulmonary disease: a meta-analysis	7
Airway granulation response to lung-implantable medical devices: a concise overview	7
“Immune mechanisms in fibrotic pulmonary sarcoidosis”. P. Weeratunga, D.R. Moller and L-P. Ho.Eur Respir Rev2022; 31: 220178	7
Immune mechanisms in fibrotic pulmonary sarcoidosis	7
Identifying risk factors for COPD and adult-onset asthma: an umbrella review	7
Sex and gender in interstitial lung diseases	7
Central sleep apnoea: not just one phenotype	7
Integrating asthma care guidelines into primary care electronic medical records: a review focused on Canadian knowledge translation tools	7
Ventilatory efficiency in pulmonary vascular diseases	7
SARS-CoV-2 post-acute sequelae in previously hospitalised patients: systematic literature review and meta-analysis	7
The role of mucin 1 in respiratory diseases	7
Identifying outcome domains to establish a core outcome set for progressive pulmonary fibrosis: a scoping review	6
Sex and gender in asthma	6
Post-tuberculosis lung impairment: systematic review and meta-analysis of spirometry data from 14 621 people	6
How will lung cancer screening and lung nodule management change the diagnostic and surgical lung cancer landscape?	6
Chronic cough: new insights and future prospects	6
Interstitial lung disease in infancy and early childhood: a clinicopathological primer	6
Nitrogen single and multiple breath washout test and lung imaging to detect treatment-related pulmonary toxicity in paediatric cancer patients and survivors: a systematic review	6
Cerebral oxidative stress, inflammation and apoptosis induced by intermittent hypoxia: a systematic review and meta-analysis of rodent data	6
A pulmonologist's guide to perform and analyse cross-species single lung cell transcriptomics	6
Changing profile of bacterial infection and microbiome in cystic fibrosis: when to use antibiotics in the era of CFTR-modulator therapy	6
Digital twins for chronic lung diseases	6
Predicting paediatric asthma exacerbations with machine learning: a systematic review with meta-analysis	6
Safety of steroids in severe community-acquired pneumonia	6
Strength of association between comorbidities and asthma: a meta-analysis	6
Diagnosis, course and management of hypersensitivity pneumonitis	6